124 related articles for article (PubMed ID: 19579616)
21. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Tsurumoto S
Anticancer Res; 1995; 15(5B):2291-6. PubMed ID: 8572640
[TBL] [Abstract][Full Text] [Related]
22. A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan.
Fujimoto K; Tomonaga M; Goto S
Anticancer Res; 2006; 26(6A):4015-8. PubMed ID: 17195451
[TBL] [Abstract][Full Text] [Related]
23. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
Suto T; Yoshida Y; Sakata Y; Ono T; Yoshida T; Yamada N; Chida N; Oohira H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of major hepatectomy for large hepatocellular carcinoma.
Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
[TBL] [Abstract][Full Text] [Related]
25. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
26. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
Paul SB; Chalamalasetty SB; Vishnubhatla S; Madan K; Gamanagatti SR; Batra Y; Gupta SD; Panda SK; Acharya SK
Oncology; 2009; 77(3-4):162-71. PubMed ID: 19641335
[TBL] [Abstract][Full Text] [Related]
27. Metachronous resection of metastatic lymph nodes in patients with hepatocellular carcinoma.
Hashimoto M; Matsuda M; Watanabe G
Hepatogastroenterology; 2009; 56(91-92):788-92. PubMed ID: 19621703
[TBL] [Abstract][Full Text] [Related]
28. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
[TBL] [Abstract][Full Text] [Related]
29. [Anticancer immunotherapy with perorally effective lentinan].
Hamuro J
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1209-15. PubMed ID: 16121931
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
31. [Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study].
Yamada J
Nippon Ganka Gakkai Zasshi; 2009 Nov; 113(11):1082-7. PubMed ID: 19994586
[TBL] [Abstract][Full Text] [Related]
32. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
33. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Ramanathan RK; Belani CP; Singh DA; Tanaka M; Lenz HJ; Yen Y; Kindler HL; Iqbal S; Longmate J; Mack PC; Lurje G; Gandour-Edwards R; Dancey J; Gandara DR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):777-83. PubMed ID: 19169683
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic liver resection for hepatocellular carcinoma: intermediate follow-up results.
Lai IR; Yeh CC; Yu SC
Hepatogastroenterology; 2009; 56(93):1082-5. PubMed ID: 19760946
[TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma].
Kim YI; Ki HS; Kim MH; Cho DK; Cho SB; Joo YE; Kim HS; Choi SK; Rew JS
Korean J Hepatol; 2009 Jun; 15(2):148-58. PubMed ID: 19581767
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy for lymph node metastases from hepatocellular carcinoma.
Toya R; Murakami R; Yasunaga T; Baba Y; Nishimura R; Morishita S; Nishi J; Beppu T; Baba H; Yamashita Y; Oya N
Hepatogastroenterology; 2009; 56(90):476-80. PubMed ID: 19579624
[TBL] [Abstract][Full Text] [Related]
40. The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.
Kaido T; Takada Y; Egawa H; Uemoto S
Hepatogastroenterology; 2009; 56(91-92):808-12. PubMed ID: 19621707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]